I’ve been reading the latest Harmony magazine and it says that Thyroid UK has had talks with the British T3 producer, Concordia International. To explain the price hike in their T3, Concordia explained to Thyroid UK that the MHRA, (Medicines and Healthcare products Regulatory Agency?) changed the standards in respect of the manufacture of the drug and it’s now difficult to produce. It goes on to say that the standards are very strict which may be why T3 is much cheaper in other parts of Europe.
Does anyone here have further information of the changes in the manufacture of liothyronine that MHRA have insisted upon?